homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

November 30, 2018

Pascal Biosciences

Pascal Biosciences, a drug development company with offices in Vancouver, B.C., and Seattle, hired Kevin M. Egan as vice president of business development, Thomas Deckwerth as vice president of therapeutic development and Larry W. Tjoelker as vice president of research. Egan has over 30 years of experience in biotech, with stints at Amgen, Icos, CMC Biologics and Borealis Biotechnology. Deckwerth has 20 years of experience in therapeutics and medical device R&D, lastly as vice president of cancer drug development at Presage Biosciences. Tjoelker has over 25 years of research experience in biotechnology, working at Icos, MacroGenics and Omeros.




Email or user name:
Password:
 
Forgot password? Click here.